NCT01604265 A Study of Sativex in the Treatment of Central Neuropathic Pain Due to Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT01600716 Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS) Status COMPLETED Phase PHASE3
NCT01599234 A Study to Evaluate the Efficacy of Sativex in Relieving Symptoms of Spasticity Due to Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT01597297 Exploratory Study to Assess the Effect of Fampridine (BIIB041) on Walking Ability and Balance in Participants With Multiple Sclerosis. Status COMPLETED Phase PHASE2
NCT01596881 Using Optical Coherence Tomography to Capture Retinal Microvascular Changes Associated With Multiple Sclerosis Status COMPLETED Phase N/A
NCT01592552 A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker Discovery Status COMPLETED Phase N/A
NCT01592097 Exploratory Study to Assess Clinical Response to Gilenya® (Fingolimod) in Hispanics With RRMS Status COMPLETED Phase N/A
NCT01587690 Immune Regulation in Multiple Sclerosis: MicroRNA and Antigen-Presenting Cells Status COMPLETED Phase N/A
NCT01585298 STudy to vAlidate telemetRic ECG Systems for firsT Dose Administration of Fingolimod (START) Status COMPLETED Phase PHASE4
NCT01578330 A 12 -Month, Open-label, Multi-center Study to Explore the Health Outcomes of FTY720 Status COMPLETED Phase PHASE4
NCT01576354 Characterization of the Effects of Prolonged-release Fampridine on Ambulatory Function in Patients With Multiple Sclerosis Status UNKNOWN Phase PHASE2
NCT01572714 Examining the Effects of a Telehealth Self-management Intervention in Multiple Sclerosis Status COMPLETED Phase NA
NCT01572207 Promoting Physical Activity Behavior in Persons With Multiple Sclerosis Status COMPLETED Phase NA
NCT01569451 Comparison of Rituximab Induction Therapy Followed by Glatiramer Acetate Status COMPLETED Phase PHASE2
NCT01563900 Continuous Positive Airway Pressure (CPAP) for Fatigue in Patients With Multiple Sclerosis (MS) and Obstructive Sleep Apnea (OSA) Status WITHDRAWN Phase NA
NCT01556685 MATRIX: Measuring Neutralizing Antibodies in the Patients Treated With Interferon Beta 1a IM, in Mexico and Colombia Status COMPLETED Phase PHASE4
NCT01555684 Functional Changes Following Percutaneous Venoplasty in Multiple Sclerosis Patients Status WITHDRAWN Phase NA